The reported statements, read against the company's own industry.
Financials view
Market Capitalization
2.25BCNY
335.25M · vs all stocks (USD)
Updated Sep 21, 2026
Revenue (TTM)
827.53MCNY
123.57M · vs all stocks (USD)
Updated Sep 21, 2026
Profit Margin
-14.02%
Updated Sep 21, 2026
Beta
0.3210x
vs all stocks
Updated Sep 21, 2026
52-Week Change
10.27%
vs all stocks
Updated Sep 21, 2026
Market Capitalization
2.25BCNY
335.25M · vs all stocks (USD)
Updated Sep 21, 2026
Enterprise Value
2.15BCNY
321.30M · vs all stocks (USD)
Updated Sep 21, 2026
Forward P/E
8.59x
Updated Sep 21, 2026
Price to Sales (TTM)
2.61x
Provider-reported. Market Capitalization ÷ Revenue (TTM) on this page gives 2.71×.Updated Sep 21, 2026
Price to Book (MRQ)
3.58x
Updated Sep 21, 2026
Enterprise to Revenue
2.60x
Updated Sep 21, 2026
Enterprise to EBITDA
55.60x
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 14.71×.Updated Sep 21, 2026
Gross Margin
5.45%
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 10.7%.Updated Sep 21, 2026
Profit Margin
-14.02%
Updated Sep 21, 2026
Operating Margin
-23.26%
Updated Sep 21, 2026
Return on Assets (TTM)
-1.49%
Updated Sep 21, 2026
Return on Equity (TTM)
-18.37%
Updated Sep 21, 2026
Revenue (TTM)
827.53MCNY
123.57M · vs all stocks (USD)
Updated Sep 21, 2026
Revenue per Share (TTM)
4.09CNYUpdated Sep 21, 2026
Quarterly Revenue Growth
-38.70%
Updated Sep 21, 2026
Gross Profit (TTM)
88.57MCNY
13.23M · vs all stocks (USD)
Updated Sep 21, 2026
EBITDA (TTM)
146.23MCNY
21.84M · vs all stocks (USD)
Updated Sep 21, 2026
Net Income (TTM)
-116.03MCNY
-17.33M · vs all stocks (USD)
Updated Sep 21, 2026
Operating Cash Flow (TTM)
195.91MCNY
29.25M · vs all stocks (USD)
Updated Sep 21, 2026
Levered Free Cash Flow (TTM)
145.29MCNY
21.70M · vs all stocks (USD)
Updated Sep 21, 2026
5-Year Average Dividend Yield
0.65%
vs all stocks
Updated Sep 21, 2026
Payout Ratio
125.00%
Updated Sep 21, 2026
Minority Interest (Equity)
3.99MCNYFY2025 · Dec 31, 2025
Revenue
978.08MCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
790.11MCNYFY2025 · Dec 31, 2025
Gross Profit
187.97MCNYFY2025 · Dec 31, 2025
Operating Income
71.11MCNY
10.62M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
41.99MCNYFY2025 · Dec 31, 2025
Income Tax Expense
21.60MCNYFY2025 · Dec 31, 2025
Net Income
20.39MCNYFY2025 · Dec 31, 2025
EBIT
57.95MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
146.23MCNYFY2025 · Dec 31, 2025
Research & Development
29.03MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
35.51MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
4.60MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
3.56MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
15.97MCNYFY2025 · Dec 31, 2025
EPS (Basic)
0.1100CNYFY2025 · Dec 31, 2025
EPS (Diluted)
0.1100CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
200.96MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
200.96MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
20.39MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
1.72MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
312.96MCNYFY2025 · Dec 31, 2025
Free Cash Flow
259.23MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
216.34MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
20.39MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
28.25MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
248.63MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
15.69MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-53.73MCNYFY2025 · Dec 31, 2025
Net Acquisitions
-2.10MCNYFY2025 · Dec 31, 2025
Purchase of Investments
-316.13MCNYFY2025 · Dec 31, 2025
Sale of Investments
205.79MCNYFY2025 · Dec 31, 2025
Other Investing Activity
6.40MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-159.77MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
449.50MCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-483.50MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-24.59MCNYFY2025 · Dec 31, 2025
Other Financing Charges
-61.87MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-120.46MCNYFY2025 · Dec 31, 2025
Shares Outstanding
200.99MSharesUpdated Sep 21, 2026
Float Shares
156.70MSharesUpdated Sep 21, 2026
% Held by Insiders
22.14%
vs all stocks
Updated Sep 21, 2026
% Held by Institutions
2.06%
vs all stocks
Updated Sep 21, 2026
Total Cash (MRQ)
253.52MCNY
37.86M · vs all stocks (USD)
Updated Sep 21, 2026
Total Cash per Share (MRQ)
1.26CNYUpdated Sep 21, 2026
Total Debt (MRQ)
244.06MCNY
36.45M · vs all stocks (USD)
Updated Sep 21, 2026
Total Debt to Equity (MRQ)
0.4029x
Updated Sep 21, 2026
Current Ratio (MRQ)
1.20x
Updated Sep 21, 2026
Book Value per Share (MRQ)
3.00CNYUpdated Sep 21, 2026
Total Assets
1.53BCNY
228.89M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
1.01BCNYFY2025 · Dec 31, 2025
Total Liabilities
843.31MCNYFY2025 · Dec 31, 2025
Total Non-current Assets
521.60MCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
4.22MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
839.10MCNYFY2025 · Dec 31, 2025
Cash
215.83MCNYFY2025 · Dec 31, 2025
Cash Equivalents
7.04MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
222.87MCNYFY2025 · Dec 31, 2025
Other Short-term Investments
115.63MCNYFY2025 · Dec 31, 2025
Accounts Receivable
220.50MCNYFY2025 · Dec 31, 2025
Inventory
33.10MCNYFY2025 · Dec 31, 2025
Accounts Payable
315.54MCNYFY2025 · Dec 31, 2025
Short-term Debt
348.31MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
134.11MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
200.99MCNYFY2025 · Dec 31, 2025
Retained Earnings
138.85MCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
689.45MCNY
102.96M · vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
8.44CNYUpdated Sep 21, 2026
52-Week High
17.90CNYUpdated Sep 21, 2026
52-Week Change
10.27%
vs all stocks
Updated Sep 21, 2026
Beta
0.3210x
vs all stocks
Updated Sep 21, 2026
50-Day MA
12.03CNYUpdated Sep 21, 2026
200-Day MA
11.85CNYUpdated Sep 21, 2026
Avg 10-Day Volume
12.66MSharesUpdated Sep 21, 2026
Avg 30-Day Volume
17.68MSharesUpdated Sep 21, 2026
Diluted EPS (TTM)
-0.5800CNYUpdated Sep 21, 2026
2 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Its free cash flow is large next to assets and equity, and more of its operating cash reaches it than in its industry.
Reads
How is this stock valued?
Close Below 40W SMA With Profitability
The price sits below its 40-week average, on three profitable years and cash above profit.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 2.62: safe zoneNotable
Altman Z-Score: 2.62
Supply Chain
Upstream position: supplies 5 industries, depends on 3Notable
Outgoing: 5.00Incoming: 3.00
Scale
Levered free cash flow is $21.7M, above the global median of $18.73MNotable